Furthermore, LPS induces the upregulation of programmed cell death ligand 1 (PD-L1) through the TLR4/MyD88/AKT/NF-κB pathway and triggers the depletion and apoptosis of tumor-infiltrating lymphocytes (TILs), consequently facilitating cancer immune evasion (66). This evidence concerns the gene NFKB1 and cancer.